FDA PROJECTS FOREIGN DRUG INSPECTION INCREASE OF 90% IN FY 1995
FDA PROJECTS FOREIGN DRUG INSPECTION INCREASE OF 90% IN FY 1995 compared to fiscal 1994, which ended Sept. 30, Division of Field Investigations Director Robert Fish told the National Association of Pharmaceutical Manufacturers meeting in Rockville, Md. Oct. 27. Fish said the 570 foreign inspections planned for the current fiscal year is substantially higher than the 300 conducted in FY 1994. Resources for the foreign inspections, including money and personnel, will "come out of domestic coverage," Fish said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth